Thursday, 1 October 2026
Thursday, 1 October 2026
- In brief
- 1Scientists replaced half of a mouse's brain with human brain cells, to study illnesses that mice do not get
- 2Surgeon general pick clears a Senate committee
- 3Sugar during antibiotics, and fewer gut bacteria
- 4WHO meets to pick the 2027 flu strains
- 5Stair climbers had fewer heart deaths
- 6Plant fats and longer lives after prostate cancer
- 7COVID rising in US wastewater
- 8Seven in ten US cancer patients pass five years
- 9First world map of breast cancer survival
- 10Richer US counties gained most against cancer
- 11Medicaid expansion and five-year cancer survival
- 12Lung cancer survival tracks county smoking
- 13Red-light therapy: some real uses, much hype
- 14High blood pressure in your thirties
- 15Five minutes more a day
- 167,000 steps did most of the work
- 17Very hard exercise mostly did not harm hearts
- 18A migraine pill tried on endometriosis tissue
- 19Isolation and memory in 24 countries
- 20Nearly half of older people have two illnesses
- 21Watching human brain cells pass messages
- 22Ultra-processed food and dementia risk
- 23More US men diagnosed with prostate cancer
1 Oct · Mind & body · In brief
Mind & body · Thursday, 1 October 2026
Mind & body, in brief
23 stories · 39 sources
Swipe up for the day in brief ↑Scroll down for the day in brief ↓
What is moving · 1 of 4
Tests that start in mice
Stanford put human brain cells into mice so that treatments for brain illnesses mice do not get can be tested in them.
What is moving · 2 of 4
Links that may not be causes
People who climbed stairs had a 39% lower risk of dying of heart disease, but the studies only watched them.
What is moving · 3 of 4
Cancer survival rising, unevenly
Seven in ten US cancer patients now live at least five years, a record.
What is moving · 4 of 4
US vaccine advice in dispute
The surgeon general nominee told senators she has seen no good evidence that vaccines cause autism.
12 sources
Mind & body, in brief
- 2Part-human part-mouse brain developed in science breakthrough
- 9A sucrose-rich diet promotes Clostridioides difficile carriage without prior antibiotics and significantly exacerbates both acute disease and long-term colonization
- 10Does red-light therapy work? What the research says
- 11Stair climbing may significantly lower cardiovascular risks
- 12Reconsidering Causal Interpretation of Stair-Climbing Epidemiology and Necessary Precautions for Cardiovascular Patients
- 13Harvard study links ultra-processed foods to higher rates of cognitive decline, dementia
- 1470 Percent of Cancer Patients Now Survive at Least Five Years, Study Finds
- 15First global breast cancer survival estimates show wide regional and income disparities
- 16Who is benefiting from the dramatic decline in U.S. cancer mortality? Place-based evidence of disparities in rates of improvement
- 17Trump's surgeon general nominee Nicole Saphier praises MMR and hepatitis B vaccines in Senate hearing
- 18Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States
- 19COVID cases are on the rise-here's how to stay healthy this winter
Scientists replaced half of a mouse's brain with human brain cells, to study illnesses that mice do not get
Swipe up for the story ↑Scroll down for the story ↓
A Stanford University team led by the neuroscientist Sergiu Pasca bred mice that grow almost none of their own cerebral cortex, the outer layer of the brain used for thinking, memory and the senses.
the mice were bred to lack more than 90% of their own cortex
this time the human cells had the space to themselves
Who is involved
Sergiu Pasca
a neuroscientist at Stanford University in California; he led the work and plans to test treatments in the mice
Who is involved
Nita Farahany
a law and philosophy professor at Duke University who sat on the project's volunteer ethics panel; she says she does not know how to regard the animals
Why it matters
Watch whether an international body for brain organoid research is set up, and whether anyone tries the same thing in bigger, longer-lived animals such as pigs or monkeys.
What's really going on
Stanford built mice whose brains are about half human by volume because drugs for brain illnesses that work in ordinary animals keep failing in patients.
What's really going on
The rules for how to treat such animals are still being written, and no international body yet oversees this work.
Why it works on people
The words part-human mouse make a reader picture an animal that thinks like a person, and the scientists quoted say there is no sign of that.
Who gains
Pasca's lab at Stanford
It now has a living animal in which to test treatments for illnesses like cerebral palsy, which it says it plans to do.
Who gains
Organoid researchers in the US
US health agencies pledged to rely less on animal tests, and the NIH announced $87 million for a new organoid centre.
Who pays
The mice
They are bred without most of their own cortex, and pups born with a whole cortex are mostly culled so the others survive.
Nobody knows yet
Whether the part-human mice feel or experience anything an ordinary mouse does not.
They behave much like ordinary mice, but there is no agreed way to measure this, and an ethicist on the project's own panel says she does not know how to regard them.
Nobody knows yet
Who will oversee research like this.
An international body was proposed in 2025, and its form, its rules and who should run it are still being worked out.
Nobody knows yet
Whether drugs tested in these mice will do better in patients.
The study did not test a drug in them, and the mice are expected to be used in a small number of labs for a few specific illnesses.
Good news
Mice born without most of their cortex did almost as well as ordinary mice on a maze memory test once human brain tissue had grown into the gap.
The short version
That's the story in short.
The whole story has 13 more parts.
or swipe up for the next storyor scroll on for the next story ↓
The whole story, in 13 parts ↓
Part 1 of 13 · Who else is involved
Hongkui Zeng
director of brain science at the Allen Institute in Seattle; she says the questions grow if this is tried in pigs or monkeys
Part 1 of 13 · Who else is involved
Juergen Knoblich
a brain-organoid researcher in Vienna, not involved; he says the data do not show smarter or more aware mice
Part 2 of 13 · How it unfolded
2018
Salk Institute scientists report the first human brain organoids implanted into mouse brains
16 Sep 2026
the Stanford mice are published in Nature
Part 2 of 13 · How it unfolded
16 Sep 2026
the Stanford mice are published in Nature
Late Sep 2026
a Nature editorial asks who should oversee the field
Part 3 of 13
Into newborn mice they placed clumps of human brain-like tissue, called organoids, grown from human stem cells over about 40 days.
Part 4 of 13
Within weeks to months the human cells divided, grew blood vessels and filled most of the empty space.
Part 5 of 13
About half of each brain ended up human by volume, though not by number of nerve cells.
Part 6 of 13
The human nerve cells connected with the rest of the mouse brain, and some sent fibres down into the spinal cord.
Part 7 of 13
The tissue also made a kind of large nerve cell linked to social skills, which mice do not have and which is found in big-brained animals such as whales and primates.
Part 8 of 13
Mice born without a cortex did worse than normal mice on a maze memory test, and mice given the human tissue almost fully closed that gap.
Part 9 of 13
When oxygen was cut, the part-human mice developed problems walking, like those in cerebral palsy; ordinary mice cope with low oxygen because they evolved living underground.
Part 10 of 13
Pasca said psychiatry has one of the lowest success rates for clinical trials, and that drugs which work well in animals fail badly in patients.
Part 11 of 13
The human tissue is still untidy: most cell types are there, but not sorted into the neat layers of a real cortex.
Part 12 of 13
In 2025 the US NIH and FDA pledged to cut animal testing for some medicines, and the NIH announced $87 million for a new organoid centre.
Part 13 of 13
The paper came out in Nature on 16 September, and an editorial in the same journal called it the most extensive merging of human brain cells into an animal so far.
7 sources
Scientists replaced half of a mouse's brain with human brain cells, to study illnesses that mice do not get
- 1Developmental xenocortication using human-derived organoids in mice
- 2Part-human part-mouse brain developed in science breakthrough
- 3Human organoids restore cognition in mice with half a brain
- 4Mice with human brain cells offer a tool to study disease. Ethicists ask: What's next?
- 5Scientists grow human brain tissue inside mice. Here's why
- 6Ethics concerns spur call for oversight of neural organoid research
- 7Lab-grown brain organoids: time for international oversight
The full story
Scientists replaced half of a mouse's brain with human brain cells, to study illnesses that mice do not get
A Stanford University team led by the neuroscientist Sergiu Pasca bred mice that grow almost none of their own cerebral cortex, the outer layer of the brain used for thinking, memory and the senses.
Into newborn mice they placed clumps of human brain-like tissue, called organoids, grown from human stem cells over about 40 days.
Within weeks to months the human cells divided, grew blood vessels and filled most of the empty space.
About half of each brain ended up human by volume, though not by number of nerve cells.
The human nerve cells connected with the rest of the mouse brain, and some sent fibres down into the spinal cord.
The tissue also made a kind of large nerve cell linked to social skills, which mice do not have and which is found in big-brained animals such as whales and primates.
Mice born without a cortex did worse than normal mice on a maze memory test, and mice given the human tissue almost fully closed that gap.
When oxygen was cut, the part-human mice developed problems walking, like those in cerebral palsy; ordinary mice cope with low oxygen because they evolved living underground.
Pasca said psychiatry has one of the lowest success rates for clinical trials, and that drugs which work well in animals fail badly in patients.
The human tissue is still untidy: most cell types are there, but not sorted into the neat layers of a real cortex.
In 2025 the US NIH and FDA pledged to cut animal testing for some medicines, and the NIH announced $87 million for a new organoid centre.
The paper came out in Nature on 16 September, and an editorial in the same journal called it the most extensive merging of human brain cells into an animal so far.
- Human brain tissue50%
- The mouse's own brain50%
Why it matters. Watch whether an international body for brain organoid research is set up, and whether anyone tries the same thing in bigger, longer-lived animals such as pigs or monkeys.
Surgeon general pick clears a Senate committee
Swipe up for the story ↑Scroll down for the story ↓
On 30 September a US Senate health committee voted along party lines to send Nicole Saphier's nomination as surgeon general to the full Senate.
The surgeon general is the US government's top doctor and public health educator.
Saphier, a radiologist who has appeared on Fox News, is President Trump's third pick, after two earlier nominees failed to win enough support.
At her hearing on 16 September she said she had seen no reputable evidence that vaccines cause autism.
Why it matters
No date is set for the full Senate vote.
Why it matters
Almost 3,300 US measles cases had been confirmed this year by 11 September, more than in all of 2025, which is why her answers on vaccines drew attention.
Who gains
Nicole Saphier
The committee vote leaves only the full Senate between her and the surgeon general's job, after two earlier nominees failed.
2 sources
Surgeon general pick clears a Senate committee
The full story
Surgeon general pick clears a Senate committee
On 30 September a US Senate health committee voted along party lines to send Nicole Saphier's nomination as surgeon general to the full Senate.
Why it matters. No date is set for the full Senate vote.
Sugar during antibiotics, and fewer gut bacteria
Swipe up for the story ↑Scroll down for the story ↓
Researchers at Memorial Sloan Kettering Cancer Center in New York recorded more than 40,000 food items eaten by 158 people with blood cancers during weeks in hospital on antibiotics.
Antibiotics kill many gut bacteria, and the variety of those bacteria matters for digestion and health.
For every extra 100 grams of high-sugar food, about one large milkshake, the drop in variety was on average 24% bigger.
The sugar also helped Enterococcus faecium, a germ behind hospital infections, to grow.
Why it matters
It is a link seen in what patients chose to eat, not a trial that cut their sugar.
Why it matters
It matches a mouse study from the University of Louisville in which a high-sugar diet let a gut germ called C. difficile settle in and made its illness worse.
How it works
Research in mice carries over only where mice work like us
How it works
Scientists test ideas in mice because they cannot test them safely in people, so a result carries over only where a mouse's body works the way ours does.
How it works · step 1 of 5
Some experiments would harm a person, so they are tried in animals such as mice first
How it works · step 2 of 5
A mouse shares much of its body's machinery with ours
How it works · step 3 of 5
Where its body works differently, the result does not carry over to people
How it works · step 4 of 5
So researchers put human parts into the mouse, or check the result in human tissue
How it works · step 5 of 5
Only a test in people finally settles whether it works in people
The twist
Mice cope with low oxygen because their ancestors lived underground, so an ordinary mouse cannot show the brain damage that low oxygen causes in a newborn baby.
The twist
The Stanford mice could show it, because the part being damaged was human.
The picture
Both were short of oxygen. Only the mouse with human brain cells developed walking problems like a child with cerebral palsy, which is the gap that makes it useful.
Seen the same day
A mouse study found a sugary diet helped a gut germ take hold, and the New York team then checked the link in the real meals of 158 patients.
Seen the same day
Light protected brain cells in mice with a Parkinson's-like illness, and the open step is whether enough light can get through a human skull.
Seen the same day
The method was run on mouse tissue first, then on tissue from six epilepsy operations, to check the same process runs in human cells.
Seen the same day
Instead of an animal, the team grew lesion tissue from three patients, and the drug worked on two of them and not on the third.
The catch
A part-human brain still sits in a mouse body with a short mouse life, so it shows how young human brain cells grow, not how a grown human brain works.
The whole
A person who takes a new medicine for a brain illness meets the last step of a chain that usually began in an animal.
The whole
Each person along that chain, from the lab bench to the clinic, sees only their own step of it.
Who pays
Cancer patients given sugary drinks during antibiotics
Doctors often suggest milkshakes or smoothies to boost nutrition, and sugary food went with a bigger loss of gut bacteria.
Nobody knows yet
Whether eating less sugar during antibiotics would protect gut bacteria.
The New York study recorded what patients chose to eat, and nobody has yet given one group less sugar and compared the two.
The full story
Sugar during antibiotics, and fewer gut bacteria
Researchers at Memorial Sloan Kettering Cancer Center in New York recorded more than 40,000 food items eaten by 158 people with blood cancers during weeks in hospital on antibiotics.
Why it matters. It is a link seen in what patients chose to eat, not a trial that cut their sugar.
WHO meets to pick the 2027 flu strains
Swipe up for the story ↑Scroll down for the story ↓
WHO experts met in the week of 21 September to choose which flu strains go into vaccines for the southern hemisphere's 2027 season.
Flu viruses keep changing, so the vaccine is updated twice a year, once for each half of the world, using samples from WHO's worldwide network of labs.
New variants can appear after the choice is made, leaving the vaccine a poorer match.
A study of 63 past seasons found a repeatable method could have improved the match in 51 of them.
Why it matters
Choosing three months later would have improved the match further in 14 of the 63 seasons, if faster vaccine methods allowed it.
Why it matters
In the US, the CDC says legal uncertainties mean its July 2025 flu vaccine advice still stands for the 2026-27 season.
Nobody knows yet
Which strains the WHO chose for the 2027 southern hemisphere flu shot, and how well they will match.
We could not read the WHO's published report on the choice, and a match can only be judged once that season's viruses circulate.
3 sources
WHO meets to pick the 2027 flu strains
- 18Interim Clinical Considerations for the Use of Seasonal Influenza Vaccines in the United States
- 22WHO Consultation on the composition of influenza virus vaccines for use in the 2027 southern hemisphere influenza season
- 23Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza viruses
The full story
WHO meets to pick the 2027 flu strains
WHO experts met in the week of 21 September to choose which flu strains go into vaccines for the southern hemisphere's 2027 season.
Why it matters. Choosing three months later would have improved the match further in 14 of the 63 seasons, if faster vaccine methods allowed it.
Stair climbers had fewer heart deaths
Swipe up for the story ↑Scroll down for the story ↓
A review of nine studies covering 480,479 people aged 35 to 84 found that regular stair climbers had a 39% lower risk of dying from heart and blood-vessel disease.
Their risk of dying from any cause was 24% lower.
The studies watched what people did and assigned nobody to climb stairs, so they cannot show the stairs caused the benefit.
Why it matters
A 2026 opinion paper argues that people who are already fitter are the ones who take the stairs, which would make stairs a sign of health rather than its cause.
Why it matters
It also warns that hard climbing can strain the hearts of some heart patients.
Nobody knows yet
Whether climbing stairs protects the heart or just marks people who are already fit.
Every study in the review watched people rather than assigning them, and a 2026 paper argues the link may run the other way.
2 sources
Stair climbers had fewer heart deaths
The full story
Stair climbers had fewer heart deaths
A review of nine studies covering 480,479 people aged 35 to 84 found that regular stair climbers had a 39% lower risk of dying from heart and blood-vessel disease.
Why it matters. A 2026 opinion paper argues that people who are already fitter are the ones who take the stairs, which would make stairs a sign of health rather than its cause.
Plant fats and longer lives after prostate cancer
Swipe up for the story ↑Scroll down for the story ↓
Researchers followed 4,884 US men whose prostate cancer had not spread, from a long-running study of male health workers, for a median of almost 13 years.
Men who ate the most saturated fat after diagnosis were 24% more likely to die than those who ate the least.
The extra deaths were mostly from heart disease and other cancers, not from prostate cancer.
Why it matters
About 3.5 million US men live with prostate cancer, often for many years, so what kills them is often something else.
Why it matters
Swapping a tenth of calories from animal fat to plant fat went with a 16% lower risk of death, though the men chose their own food.
2 sources
Plant fats and longer lives after prostate cancer
The full story
Plant fats and longer lives after prostate cancer
Researchers followed 4,884 US men whose prostate cancer had not spread, from a long-running study of male health workers, for a median of almost 13 years.
Why it matters. About 3.5 million US men live with prostate cancer, often for many years, so what kills them is often something else.
COVID rising in US wastewater
Swipe up for the story ↑Scroll down for the story ↓
COVID virus levels in US wastewater have risen steadily since July, most in the western and southern states, Scientific American reported on 21 September.
Positive tests are rising too, but hospital admissions have not followed yet.
Nearly half of current samples are descendants of a strain called XFG, which has led infections for more than a year, so most immune systems have met something close to it.
Why it matters
This year's updated vaccines are aimed at XFG.
Why it matters
Infection still causes long COVID, though nobody can yet say how often.
Nobody knows yet
Whether this autumn's COVID rise will reach US hospitals.
Virus in wastewater and positive tests are up, and hospital admissions have not risen yet.
1 source
COVID rising in US wastewater
The full story
COVID rising in US wastewater
COVID virus levels in US wastewater have risen steadily since July, most in the western and southern states, Scientific American reported on 21 September.
Why it matters. This year's updated vaccines are aimed at XFG.
Seven in ten US cancer patients pass five years
Swipe up for the story ↑Scroll down for the story ↓
In January 2026 the American Cancer Society, a US charity that counts the country's cancers, reported that 70% of people diagnosed between 2015 and 2021 were alive five years later, compared with people without cancer.
That is the highest it has recorded, up from about half in the mid-1970s.
Survival with myeloma, a bone-marrow cancer, rose from 32% to 62% since the 1990s, and with liver cancer from 7% to 22%.
Why it matters
The society's chief scientist named less smoking first among the reasons: the share of active smokers fell from 44% to 11% since the 1960s.
Why it matters
The same report projected more than 2 million new US cases and over 625,000 deaths in 2026.
Good news
Seven in ten people diagnosed with cancer in the US between 2015 and 2021 were alive five years later, the highest share the American Cancer Society has recorded. In the mid-1970s it was about half.
Good news
Survival with myeloma, a bone-marrow cancer, rose from 32% to 62% since the 1990s, and survival with liver cancer from 7% to 22%.
2 sources
Seven in ten US cancer patients pass five years
The full story
Seven in ten US cancer patients pass five years
In January 2026 the American Cancer Society, a US charity that counts the country's cancers, reported that 70% of people diagnosed between 2015 and 2021 were alive five years later, compared with people without cancer.
Why it matters. The society's chief scientist named less smoking first among the reasons: the share of active smokers fell from 44% to 11% since the 1960s.
First world map of breast cancer survival
Swipe up for the story ↑Scroll down for the story ↓
In July the WHO published the first five-year breast cancer survival estimates for all 194 of its member countries, for women diagnosed from 2017 to 2021.
The global middle figure was 77.8%.
It ranged from 39.1% in the WHO's African region to 88.5% in the Americas, and from 41.9% in low-income countries to 87.3% in high-income ones.
Only 67 countries had cancer registries with real survival data, so the rest were estimated.
Why it matters
Survival was lowest where breast cancer is found at a later stage.
Why it matters
The figures are meant as a starting point for the WHO's goal of cutting early breast cancer deaths by 2.5% a year.
Who pays
Women with breast cancer in the WHO's African region
Five-year survival there was 39.1%, against 88.5% in the Americas, and survival was lowest where cancers are found late.
Nobody knows yet
How many women actually survive breast cancer in most countries.
Only 67 of 194 countries had registry data, so the rest of the WHO's figures come from a statistical model.
2 sources
First world map of breast cancer survival
The full story
First world map of breast cancer survival
In July the WHO published the first five-year breast cancer survival estimates for all 194 of its member countries, for women diagnosed from 2017 to 2021.
Why it matters. Survival was lowest where breast cancer is found at a later stage.
Richer US counties gained most against cancer
Swipe up for the story ↑Scroll down for the story ↓
US cancer death rates fell 32% from 1991 to 2019.
A 2026 study of 2,954 counties in the British Journal of Cancer found that coastal, city and higher-income counties improved first and fastest.
The counties with the highest death rates to begin with also improved a lot.
Why it matters
The national fall is real, and where a person lives changed how much of it reached them.
1 source
Richer US counties gained most against cancer
The full story
Richer US counties gained most against cancer
US cancer death rates fell 32% from 1991 to 2019.
Why it matters. The national fall is real, and where a person lives changed how much of it reached them.
Medicaid expansion and five-year cancer survival
Swipe up for the story ↑Scroll down for the story ↓
Medicaid is US public health insurance for people on low incomes, and from 2014 most states widened who could get it.
A 2025 study compared 1,423,983 cancer cases in adults aged 18 to 59 in 26 states that widened it and 12 that did not.
Five-year survival rose more in the states that widened it, by about 2.6 percentage points more in rural areas and about 1.5 more in high-poverty areas.
Why it matters
The gains were biggest for pancreatic, lung and bowel cancer.
Who gains
People with cancer in rural and high-poverty areas of states that widened Medicaid
Their five-year survival rose more than in states that did not widen it.
1 source
Medicaid expansion and five-year cancer survival
The full story
Medicaid expansion and five-year cancer survival
Medicaid is US public health insurance for people on low incomes, and from 2014 most states widened who could get it.
Why it matters. The gains were biggest for pancreatic, lung and bowel cancer.
Lung cancer survival tracks county smoking
Swipe up for the story ↑Scroll down for the story ↓
A 2026 study linked US cancer registry data covering 85% of the population to county smoking rates, air pollution and social conditions.
People with lung cancer in counties where more than 20% of adults smoke had a 14% higher risk of dying than those in counties with the lowest smoking.
Living with fine air pollution above 12 micrograms per cubic metre also went with lower survival.
Why it matters
The study used county figures, not each patient's own smoking, so it shows where the risk gathers rather than why.
1 source
Lung cancer survival tracks county smoking
The full story
Lung cancer survival tracks county smoking
A 2026 study linked US cancer registry data covering 85% of the population to county smoking rates, air pollution and social conditions.
Why it matters. The study used county figures, not each patient's own smoking, so it shows where the risk gathers rather than why.
Red-light therapy: some real uses, much hype
Swipe up for the story ↑Scroll down for the story ↓
Helmets, masks and beds that shine red and near-infrared light are sold for everything from ageing skin to ADHD, and one projection puts the market above $1 billion by 2030.
A 2025 review by more than 20 specialists found it worked for some ulcers, nerve damage, skin burns from radiation and pattern hair loss.
The US FDA has approved one device, for dry age-related macular degeneration, an eye disease.
Why it matters
The leading idea is that an enzyme in mitochondria, the cell's power plants, absorbs the light and makes more energy.
Why it matters
Brain benefits have been seen in mice with a Parkinson's-like illness, but getting enough light through a human skull is still unsolved.
How it works
Light protected brain cells in mice with a Parkinson's-like illness, and the open step is whether enough light can get through a human skull.
The idea, in story 3: Research in mice carries over only where mice work like us →Who gains
Makers of red-light devices
Proven uses for a few conditions lend weight to a market projected above $1 billion by 2030, while experts warn of considerable hype around other uses.
1 source
Red-light therapy: some real uses, much hype
The full story
Red-light therapy: some real uses, much hype
Helmets, masks and beds that shine red and near-infrared light are sold for everything from ageing skin to ADHD, and one projection puts the market above $1 billion by 2030.
Why it matters. The leading idea is that an enzyme in mitochondria, the cell's power plants, absorbs the light and makes more energy.
High blood pressure in your thirties
Swipe up for the story ↑Scroll down for the story ↓
Researchers used national health insurance records to follow 291,887 Koreans from age 30 to 40, then for about ten years more.
Those whose top blood-pressure number ran about 10 points above their peers for a decade had a 27% higher risk of heart disease after 40.
Their risk of kidney disease was 22% higher.
Why it matters
Doctors quoted said raised readings in people under 40 are often watched rather than treated.
1 source
High blood pressure in your thirties
The full story
High blood pressure in your thirties
Researchers used national health insurance records to follow 291,887 Koreans from age 30 to 40, then for about ten years more.
Why it matters. Doctors quoted said raised readings in people under 40 are often watched rather than treated.
Five minutes more a day
Swipe up for the story ↑Scroll down for the story ↓
An analysis of data from 150,000 adults in the UK, the US and Scandinavia was reported by BBC Future in May 2026.
It estimated that five extra minutes a day of moderate activity could prevent about one in ten early deaths.
The gain is largest for people who do almost nothing, and smaller for people who are already active.
Why it matters
It is an estimate from data on how active people were, not a trial.
Why it matters
It points the same way as step-count studies, which find most of the benefit at the low end.
2 sources
Five minutes more a day
The full story
Five minutes more a day
An analysis of data from 150,000 adults in the UK, the US and Scandinavia was reported by BBC Future in May 2026.
Why it matters. It is an estimate from data on how active people were, not a trial.
7,000 steps did most of the work
Swipe up for the story ↑Scroll down for the story ↓
A review of 57 studies with more than 160,000 people who wore step counters for several years found 7,000 steps a day brought most of the benefit linked to 10,000.
Compared with 2,000 steps, 7,000 went with a 25% lower risk of heart disease and a 47% lower risk of dying during the studies.
It was published in Lancet Public Health in August 2025.
Why it matters
Going past 7,000 added only a modest extra benefit.
The full story
7,000 steps did most of the work
A review of 57 studies with more than 160,000 people who wore step counters for several years found 7,000 steps a day brought most of the benefit linked to 10,000.
Why it matters. Going past 7,000 added only a modest extra benefit.
Very hard exercise mostly did not harm hearts
Swipe up for the story ↑Scroll down for the story ↓
A review from Queensland University of Technology in Australia, accepted for publication in December 2025, read 14 studies on whether years of very long, hard exercise harm the heart.
Most found it was not harmful. Some found the benefit stops growing beyond a certain amount.
Only two suggested extra exercise could become harmful, and both had serious problems in how they were done.
Why it matters
Every one of the 14 studies had possible sources of bias, which the authors say weakens them.
Why it matters
WHO guidelines advise at least 150 to 300 minutes a week of moderate activity.
Good news
A review of 14 studies found that years of very long, hard exercise mostly did not harm the heart.
1 source
Very hard exercise mostly did not harm hearts
The full story
Very hard exercise mostly did not harm hearts
A review from Queensland University of Technology in Australia, accepted for publication in December 2025, read 14 studies on whether years of very long, hard exercise harm the heart.
Why it matters. Every one of the 14 studies had possible sources of bias, which the authors say weakens them.
A migraine pill tried on endometriosis tissue
Swipe up for the story ↑Scroll down for the story ↓
Endometriosis is tissue like the womb lining growing outside the womb, and it has few treatments that do not work through hormones.
Researchers looked for existing drugs that might act on a protein called ROR1, which is raised in endometriosis lesions.
In tissue grown from three patients' lesions, two responded and one did not.
Why it matters
Re-using a drug already approved for something else can be faster than inventing one.
How it works
Instead of an animal, the team grew lesion tissue from three patients, and the drug worked on two of them and not on the third.
The idea, in story 3: Research in mice carries over only where mice work like us →1 source
A migraine pill tried on endometriosis tissue
The full story
A migraine pill tried on endometriosis tissue
Endometriosis is tissue like the womb lining growing outside the womb, and it has few treatments that do not work through hormones.
Why it matters. Re-using a drug already approved for something else can be faster than inventing one.
Isolation and memory in 24 countries
Swipe up for the story ↑Scroll down for the story ↓
A 2025 study pooled five long-running ageing studies covering 101,581 older people in 24 countries.
The link was weaker in countries with stronger welfare systems and richer economies.
Why it matters
The researchers used a method meant to reduce the chance that the link runs the other way, with failing memory making people withdraw, and the link held.
Why it matters
The WHO says isolation and loneliness affect about a quarter of older people.
Who pays
Older people who are isolated in poorer countries
The link between isolation and weaker memory was stronger where welfare systems and economies were weaker.
2 sources
Isolation and memory in 24 countries
The full story
Isolation and memory in 24 countries
A 2025 study pooled five long-running ageing studies covering 101,581 older people in 24 countries.
Why it matters. The researchers used a method meant to reduce the chance that the link runs the other way, with failing memory making people withdraw, and the link held.
Nearly half of older people have two illnesses
Swipe up for the story ↑Scroll down for the story ↓
A 2025 review of 49 studies covering 729,043 people aged 60 or over found that 46% had two or more long-term illnesses at the same time.
The share was 48% in women and 41% in men, and lower in studies from China than elsewhere.
The WHO says there were 1.1 billion people aged 60 or over in 2023, and the number will nearly double by 2050.
Why it matters
The WHO estimates that about 15% of adults aged 70 and over live with a mental disorder, most often anxiety or depression.
Why it matters
Being 70 or older raised the odds of having several illnesses at once.
2 sources
Nearly half of older people have two illnesses
The full story
Nearly half of older people have two illnesses
A 2025 review of 49 studies covering 729,043 people aged 60 or over found that 46% had two or more long-term illnesses at the same time.
Why it matters. The WHO estimates that about 15% of adults aged 70 and over live with a mental disorder, most often anxiety or depression.
Watching human brain cells pass messages
Swipe up for the story ↑Scroll down for the story ↓
Johns Hopkins researchers hit living brain tissue with an electric pulse and froze it a fraction of a second later, to photograph brain cells passing messages.
They did it first in mouse tissue, then in tissue removed from six people having surgery for epilepsy.
The same recycling of tiny message-carrying bubbles seen in the mice was running in the human cells.
Why it matters
The junctions where brain cells pass messages go wrong in Parkinson's disease.
How it works
The method was run on mouse tissue first, then on tissue from six epilepsy operations, to check the same process runs in human cells.
The idea, in story 3: Research in mice carries over only where mice work like us →1 source
Watching human brain cells pass messages
The full story
Watching human brain cells pass messages
Johns Hopkins researchers hit living brain tissue with an electric pulse and froze it a fraction of a second later, to photograph brain cells passing messages.
Why it matters. The junctions where brain cells pass messages go wrong in Parkinson's disease.
Ultra-processed food and dementia risk
Swipe up for the story ↑Scroll down for the story ↓
Harvard researchers followed 5,370 US adults with an average age of 64 for nearly nine years, testing memory and attention every two years.
Those who reported eating the most ultra-processed food, such as sugary drinks, deli meats and fast food, had a 58% higher risk of dementia than those who ate the least.
Those eating the most whole, little-processed food had a 41% lower risk.
Why it matters
Diet was asked about once, at the start.
Why it matters
Ultra-processed food is also linked to diabetes, high blood pressure and obesity, which are known risks for memory loss.
1 source
Ultra-processed food and dementia risk
The full story
Ultra-processed food and dementia risk
Harvard researchers followed 5,370 US adults with an average age of 64 for nearly nine years, testing memory and attention every two years.
Why it matters. Diet was asked about once, at the start.
More US men diagnosed with prostate cancer
Swipe up for the story ↑Scroll down for the story ↓
An American Cancer Society study published on 2 September 2025 found more US men were diagnosed with prostate cancer from 2014 to 2021, reversing the fall from 2007 to 2014.
Advanced cases rose by 6% a year in men aged 55 to 69, and by 6.2% a year in men aged 70 and over.
Black men were twice as likely to die of it as white men.
Why it matters
The researchers said screening rates, access to care, environment and genes could all help explain the gaps between groups.
Who pays
Black men in the US
They were twice as likely as white men to die of prostate cancer.
1 source
More US men diagnosed with prostate cancer
The full story
More US men diagnosed with prostate cancer
An American Cancer Society study published on 2 September 2025 found more US men were diagnosed with prostate cancer from 2014 to 2021, reversing the fall from 2007 to 2014.
Why it matters. The researchers said screening rates, access to care, environment and genes could all help explain the gaps between groups.
That's the whole Mind & body day.
23 stories, 39 sources.